On September 10, 2021 T-Cure Bioscience, Inc., a privately held company focused on developing T cell receptor (TCR) therapy products for the treatment of solid tumors, reported that the management will present virtually at the following upcoming healthcare conferences (Press release, T-Cure Bioscience, SEP 10, 2021, View Source [SID1234590211]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

5th Annual Cell Gene Therapy World Asia 2021, Singapore

Gang Zeng, Ph.D., Chief Executive Officer, will present virtually on Wednesday, September 16, 2021, at 11:30 am. (Singapore Time). The title of his presentation is "Targeting Solid Tumors with Novel TCR-T Strategies"
2021 Baird Global Healthcare Conference

Erika von Euw, Ph.D. Senior Director of Translational Research, and Gang Zeng, Ph.D. will give a presentation on T-Cure Bioscience on Wednesday, September 15, at 3:10 p.m. (EDT).
2021 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Erika von Euw, PhD, and Gang Zeng, Ph.D. will give a presentation on T-Cure Bioscience on Thursday, September 23, at 12:25 pm (EDT).